A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution
Gold, M.H.; Rao, J.; Goldman, M.P.; Bridges, T.M.; Bradshaw, V.L.; Boring, M.M.; Guider, A.N.
Journal of Drugs in Dermatology Jdd 4(1): 64-70
2005
ISSN/ISBN: 1545-9616 PMID: 15696987 Document Number: 8133
Blue light sources have been shown to be effective in the treatment of mild to moderate inflammatory acne vulgaris lesions. We evaluated the safety and efficacy of a new blue light source in the treatment of mild to moderate inflammatory acne vulgaris in comparison to topical 1% clindamycin solution. Blue light therapy reduced inflammatory acne vulgaris lesions by an average of 34%, as compared to 14% for topical 1% clindamycin solution. The blue light source presented in this report is a safe and effective treatment option available to our patients with mild to moderate inflammatory acne lesions.
Document emailed within 1 workday
